Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...
This proposed rule signals an important shift in the federal approach to obesity management, aligning with the medical ...
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
Pennsylvania's Medicaid spending per enrollee on Wegovy, Zepbound, and other anti-obesity drugs was third-highest in the ...
The Biden administration has unveiled a major proposal to expand Medicare and Medicaid coverage for anti-obesity drugs, ...
Obesity continues to plague New Yorkers, affecting almost two out of every three adults in our state. That’s why I’m pushing ...
On Tuesday, November 26, the Centers for Medicare and Medicaid Services (CMS) proposed a new statutory interpretation that, if finalized, would result in expanded Medicare and Medicaid coverage for ...
The Biden administration proposed expanding coverage of weight loss medication to Medicaid and Medicare recipients. RFK Jr.